Esprit
Payments companies reported to CMS as associated with Esprit. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Esprit, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Esprit
These are the largest totals companies reported as associated with Esprit. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Brian Derubertis | New York, NY | Vascular Surgery | $108,484.74 |
| Subhash Banerjee | Dallas, TX | Cardiovascular Disease | $58,500.00 |
| John Phillips | Columbus, OH | Interventional Cardiology | $40,929.75 |
| Alykhan Lalani | Marietta, GA | Vascular Surgery | $34,509.31 |
| Danielle Bajakian | New York, NY | Vascular Surgery | $24,104.83 |
| Ajit Rao | New York, NY | Vascular Surgery | $21,983.63 |
| John Corl | Cincinnati, OH | Interventional Cardiology | $21,415.64 |
| Matthew Bunte | Kansas City, MO | Interventional Cardiology | $20,165.44 |
| Michael Siah | Dallas, TX | Vascular Surgery | $16,147.45 |
| Prakash Krishnan | New York, NY | Interventional Cardiology | $15,978.94 |
Prescribed Esprit?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.